LEVOMILNACIPRAN Drug Patent Profile
✉ Email this page to a colleague
When do Levomilnacipran patents expire, and when can generic versions of Levomilnacipran launch?
Levomilnacipran is a drug marketed by Amneal Pharms Co, Aurobindo Pharma Ltd, Hikma, and Prinston Inc. and is included in four NDAs.
The generic ingredient in LEVOMILNACIPRAN is levomilnacipran hydrochloride. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the levomilnacipran hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Levomilnacipran
A generic version of LEVOMILNACIPRAN was approved as levomilnacipran hydrochloride by PRINSTON INC on March 20th, 2023.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LEVOMILNACIPRAN?
- What are the global sales for LEVOMILNACIPRAN?
- What is Average Wholesale Price for LEVOMILNACIPRAN?
Summary for LEVOMILNACIPRAN
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| DailyMed Link: | LEVOMILNACIPRAN at DailyMed |
US Patents and Regulatory Information for LEVOMILNACIPRAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharms Co | LEVOMILNACIPRAN HYDROCHLORIDE | levomilnacipran hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 210790-001 | Feb 4, 2019 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aurobindo Pharma Ltd | LEVOMILNACIPRAN HYDROCHLORIDE | levomilnacipran hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 210826-003 | Jan 6, 2023 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Amneal Pharms Co | LEVOMILNACIPRAN HYDROCHLORIDE | levomilnacipran hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 210790-004 | Feb 4, 2019 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | LEVOMILNACIPRAN HYDROCHLORIDE | levomilnacipran hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 210732-004 | Nov 5, 2020 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aurobindo Pharma Ltd | LEVOMILNACIPRAN HYDROCHLORIDE | levomilnacipran hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 210826-004 | Jan 6, 2023 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
